Tianjin pharmaceutical industry, such as 19 drug companies were exposed to the list of unqualified products in Guangdong

Information Picture "2012 The fourth quarter Guangdong province drug Quality Notice" published this news (Wen/table reporter Zhao) yesterday, the Guangdong Province Food and Drug Administration announced the 2012 fourth quarter Guangdong province drug quality notice. Sampling results show that 19 of Foshan pharmaceutical business units (or medical institutions) into the provincial drug quality Bulletin "blacklist." Reporters from the drug Quality Bulletin published on the list found that, in addition to the usual drug retail pharmacies and suppliers were sampling substandard drugs, this time some medical institutions unqualified drugs are also exposed. The exposure of the 19 drug management units or medical institutions of the counterfeit drugs are mainly three yellow tablets, seven children tea granules, colchicine tablets, such as the family commonly used drugs. Unqualified items are also concentrated in dissolution, content determination, visible foreign bodies and loading differences. The exposure of the drug business Unit list, the most concern is the Southwest Street, Sanshui District Rehabilitation Specialist Hospital, shunde New century urology hospital and Gaoming District CDC each has a group of drugs are checked out as "bad medicine." At the same time, the geological rehabilitation Specialist hospital secretion of the capsule is also identified as counterfeit or counterfeit drugs, the manufacturer did not produce the relevant lot number of products. For the outpatient sales of vitamin A sour cream content of the situation, yesterday, Gaoming District CDC responded to this reporter said, has now learned from the Internet drug testing results, unqualified batches of drugs have been returned to the supplier. Relevant officials said, because the district CDC's outpatient volume is small, from January 1 this year, Gaoming District CDC has completely stopped outpatient service, all drugs have been returned to the supplier to deal with. According to the provincial Food and Drug Administration of the investigation and disposal arrangements, Foshan Food and Drug Supervision Bureau will be exposed to the exposure of drug companies to carry out follow-up inspection. The investigation and disposal will be reported to the provincial authorities before 31st.